Gentamicin serum concentrations in patients with gentamicin-PMMA beads for infected hip joints: A prospective observational cohort study

Therapeutic Drug Monitoring

Volumn 34, Issue 1, 2012, Pages 67-71

  De Klaver, Paul A G ^a   Hendriks, Johannes G E ^a   Van Onzenoort, Hein A W ^b   Schreurs, Berend W ^b   Touw, Daan J ^c   Derijks, Luc J J ^a  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Apotheek Haagse Ziekenhuizen ^*  (Netherlands)

Author keywords

gentamicin; gentamicin serum concentrations; gentamicin PMMA beads; infected hip joints; nephrotoxicity

Indexed keywords

CREATININE; GENTAMICIN BONE CEMENT;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; COXITIS; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG IMPLANTATION; DRUG SAFETY; FEMALE; HUMAN; IMMUNOASSAY; LIMIT OF QUANTITATION; MALE; NEPHROTOXICITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COHORT STUDIES; DRUG IMPLANTS; GENTAMICINS; HIP JOINT; HUMANS; JOINT DISEASES; METHYLMETHACRYLATES; MIDDLE AGED;

EID: 84856104613     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31823d7b89     Document Type: Article

References (16)

1. College Ter Beoordeling van Geneesmiddelen. SPC Septopal [Web site]. July 6, 2009. Available at: Http://db.cbg-meb.nl/IB-teksten/h07618-h12500.pdf. Accessed July 29, 2010.
2. de Klaver PA, Koning J, Janssen RPA, et al. High systemic gentamicin levels and ototoxicity after implantation of gentamicin beads in a 70-year-old man-A case report. Acta Orthop. 2009;80:734-736.
3. Raveh D, Kopyt M, Hite Y, et al. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM. 2002;95:291-297. (Pubitemid 34537761)
4. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a oncedaily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39:650-655.
5. Walenkamp GH, Vree TB, van Rens TJ. Gentamicin-PMMA beads. Clin Orthop Relat Res. 1986;205:171-183.
6. Wahlig H, Dingeldein E, Bergmann R, et al. The release of gentamicin from polymethylmethylacrylate beads. J Bone Joint Surg Br. 1978;60-B: 270-275.
7. Salvati EA, Callaghan JJ, Brause BD, et al. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res. 1986;207:83-93.
8. Walenkamp G, Vree T. Treatment of a patient with impaired renal function with gentamicin-PMMA beads. Arch Orthop Trauma Surg. 1981;99: 137-141. (Pubitemid 12200196)
9. Walenkamp G. Pharmacological and clinical results with gentamicin-PMMA beads in osteomyelitis. In: Van Rens Th, Kayser F, eds. Local Antibiotic Treatment in Osteomyelitis and Soft-Tissue Infections, International Congress Series 556. [S. 9]. Amsterdam; Excerpta Medica; 1981.
10. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994;331:1449-1450. (Pubitemid 24348362)
11. Houghton DC, English J, Bennett WM. Chronic tubulointerstitial nephritis and renal insufficiency associated with long-term "subtherapeutic" gentamicin. J Lab Clin Med. 1988;112:694-703. (Pubitemid 19022454)
12. Matzke GR, Lucarotti RL, Shapiro HS. Controlled comparison of gentamicin and tobramycin nephrotoxicity. Am J Nephrol. 1983;3:11-17. (Pubitemid 13125500)
13. Paterson DL, Robson JM, Wagener MM. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med. 1998;13:735-739. (Pubitemid 28523562)
14. Aronson JK, Reynolds DJ. ABC of monitoring drug therapy. Aminoglycoside antibiotics. BMJ. 1992;305:1492-1424.
15. Coventry MB, Beckenbaugh RD, Nolan DR, et al. 2,012 total hip arthroplasties. A study of postoperative course and early complications. J Bone Joint Surg Am. 1974;56:273-284.
16. Jung J, Schmid NV, Kelm J, et al. Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci. 2009;6:265-273.